The 5G-OR Program is a winner of the joint Franco-German Program for the development of Innovative Applications for 5G Private Networks

The 5G-OR Program is a winner of the joint Franco-German Program for the development of Innovative Applications for 5G Private Networks

Berlin, Mannheim, Rennes, Reutlingen, Strasbourg and Tuttlingen
February 3rd, 2022

5G-OR is one of the 4 winning projects jointly selected by the Federal Ministry of Economics and Climate Action in Germany and the Ministry of Economy, Finance and Relaunch in France for the call “Technical developments and application ecosystems for 5G private networks”. The joint Franco-German 5G-OR project takes up the challenge in the healthcare domain. It will explore the benefits of a 5G-enabled operating room ecosystem – a fundamental hospital component – to support medical and paramedical teams to improve patient outcome. The ambition is to strengthen Europe’s position in the 5G-enabled medical technology arena by establishing an innovation ecosystem for the development of new products and quality services.

Towards the hospital of the FUTURE

Digitisation is now being integrated into the modern hospital infrastructure. In this context, wireless communication technology is emerging as a central element of a hospital’s future environment with the need to achieve rapid and secure data transmission and analysis. The goal of 5G-OR is to create a demonstrator of a Franco-German 5G private network application ecosystem for hospitals with a specific focus on the Operating Room (OR) environment. The OR is a highly suitable environment to demonstrate the value of the intra-hospital 5G private network as it is the most concentrated node of healthcare complexity with data-dense and logistics-heavy requirements. In addition, the OR is the highest risk environment for patient safety and a major cost centre for the hospital.

5G-OR is centred around the development of the next generation of a 5G-enabled OR ecosystem intended to improve patient outcome. The underlying concept is that data-driven and Artificial Intelligence assisted surgery within a digital OR will enable more accurate and precise operations as well as fewer complications. The OR generates massive and disparate data from a multitude of sources. Here, the challenge is to make data usable for example by providing real-time feedback to medical staff. The 5G communication technology holds the capacity to enable efficient exploitation of the data generated in the OR. It is expected that efforts towards standardisation requirements for quality service and industrialisation will take the next-generation OR to a new level of service. 5G-OR will assemble these elements into a workable and reproducible package and subsequently validate its worth and interoperability with cross-border clinical use cases.

Four clinical use cases

The consortium has selected four use cases to be operated in the Franco-German 5G ecosystem to demonstrate the value of 5G private networks in the OR. The first two use cases tackle the decision-making in the OR for better patient safety through real-time analysis of massive data. The teams will use Artificial Intelligence to continuously analyse patient vital signs and surgical video, transmitted by 5G wireless medical devices for the detection of early warning signs of potential complications. Another use case pertains to remote-enabled robotic telesurgery powered by real-time data with the goal to perform remote cross-border robotic telesurgery using a 5G network connection. The fourth use case targets the optimisation of the complex logistics of the OR environment. The consortium will evaluate the benefits of 5G-enabled logistics support in the OR by autonomous mobile robotic assistant providing devices, materials, and instruments required for surgery.

5G-OR: Four clinical use cases in a Franco-German 5G ecosystem

A unique multidisciplinary consortium

The 5G-OR consortium is well balanced between R&D, Healthcare, and business. It is leveraging strong cooperation between complementary French and German partners, who have a common vision of the digital OR for better patient care. This includes hospitals and R&D centres : Institute Fraunhofer IPA in Mannheim, Institute of Image-Guided Surgery in Strasbourg, Institute of Research and Technology b<>com in Rennes, Charité University Hospital in Berlin, Reutlingen University, together with an innovative large company and SMEs : Karl Storz in Tuttlingen, SectorCon in Berlin and RDS in Strasbourg. Partners in 5G-OR are leaders in all aspects needed for the success of the project and have already made significant contributions to solving critical elements of this global vision.

5G-OR, Partenaires

Project profile

5G-OR – Establishing the next generation of a 5G-enabled operating room ecosystem to improve patient outcome, Project Link

Duration: Three years from January 1, 2022
Budget and Funding volume:  Total Budget: 5,9 M€;         Total Funding: TBD;

Project partners


Fraunhofer IPA


Reutlingen University

Charité – Universitätsmedizin Berlin

SectorCon GmbH


b<>com Institute of Research and Technology

RDS (Rhythm Diagnostic Systems)


Contacts project coordinators

Fraunhofer IPAIHU Strasbourg
M. Johannes Horsch
Tel.  +49 621
M. Jean-Luc Dimarcq
Tel.  +33 3 90 41 36 00jean-luc.dimarcq@localhost







Predictive and personalized medicine of pancreatic cancer I AAP générique ANR 2021 I PRCI Projects

Predictive and personalized medicine of pancreatic cancer I AAP générique ANR 2021 I PRCI Projects

Project CancerProfile
IHU Strasbourg + Luxembourg Institute of Health.

With a 5-year survival rate remaining in the single digits, pancreatic ductal adenocarcinoma cancer (PDAC) has the poorest prognosis of all digestive cancers due to the lack of early diagnosis and limited response to treatments. It is the deadliest worldwide, with a mortality which is predicted to increase in western countries as population age and levels of obesity rise. It often develops without apparent symptoms, and the diagnosis is typically established late in the progression of the disease, at which point only 15 to 20% of patients are eligible for surgical resection, which remains the only curative treatment. Thus, palliative chemotherapy remains a mainstay in the management of this disease. However, the strong resistance to currently used chemotherapeutic agents represents a major treatment bottleneck, and the development of effective therapeutic approaches to fight PDAC is still an urgent medical need.


CancerProfile is a multidisciplinary translational research project aimed at improveing early diagnosis and prediction of PDAC tumor response to treatments, combining cutting edge Artificial Intelligence-augmented histological imaging and innovative functional profiling of patient tumor-derived organoids, to foster precision medicine of PDAC. The project will lay the foundation for a large clinical study to evaluate the implementation of personalized treatment for PDAC patients. It will lead to the establishment of a unique biobanking and database organization, that can serve as a platform for other basic and translational European research projects.

ENSIST: A new collaboration between InSimo and IHU Strasbourg, supported by the Region Grand Est

ENSIST: A new collaboration between InSimo and IHU Strasbourg, supported by the Region Grand Est

In partnership with the IHU Strasbourg, InSimo has embarked on the development of simulation modules dedicated to learning new surgical techniques using endoscopy approach with the launching of the ENSIST project supported by the Grand Est Region. The simulation modules will be carried through with the IHU Strasbourg, allowing ENSIST to lay a solid foundation for collaboration with a view to building a close and long-lasting partnership. Through this project, InSimo will benefit from the input of medical experts from the institute who will support its development from defining training needs to the implementation of training, and will validate the pedagogical value of the simulator.

The development of the two simulation modules will be supervised by Prof. Lee Swanström, Director of Innovation (IHU Strasbourg) and Prof. Silvana Perretta, Director of Education (IHU Strasbourg). Therefore, through this partnership, InSimo will be able to count on the support of the institute’s resources for the management of preclinical and clinical research with a study that will be conducted to validate patient-specific simulation of stomach deformation.


Photo credit: InSimo

In 2020, the ENSIST project won the R&D&I scheme set up to support collaborative R&D and innovation projects.
This project has the support of the Grand Est Region, BioValleyFrance and BPI France providing significant support for a project estimated at over a million euros.

For more information, the press release in English